Phoenix Wealth Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,620
Closed -$415K 118
2023
Q4
$415K Sell
5,620
-113
-2% -$7.41K 0.29% 64
2023
Q3
$391K Sell
5,733
-166
-3% -$14.1K 0.23% 61
2023
Q2
$554K Sell
5,899
-300
-5% -$23.4K 0.32% 47
2023
Q1
$420K Sell
6,199
-215
-3% -$13.8K 0.26% 52
2022
Q4
$318K Sell
6,414
-935
-13% -$38.2K 0.19% 73
2022
Q3
$239K Buy
+7,349
New +$303K 0.24% 93
2022
Q2
Sell
-10,901
Closed -$749K 115
2022
Q1
$749K Buy
10,901
+1,442
+15% +$105K 0.77% 32
2021
Q4
$736K Buy
9,459
+3,343
+55% +$295K 0.56% 46
2021
Q3
$584K Buy
6,116
+91
+2% +$9.61K 0.44% 61
2021
Q2
$735K Buy
6,025
+93
+2% +$11.1K 0.53% 54
2021
Q1
$786K Buy
5,932
+1,466
+33% +$201K 0.61% 44
2020
Q4
$592K Buy
+4,466
New +$540K 0.45% 51

Other funds holding EXAS

Phoenix Wealth Advisors's EXAS Position: Q1 2024 in Review

Phoenix Wealth Advisors sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 5,620 shares — an estimated $415K sold.

Phoenix Wealth Advisors first reported a position in EXAS in Q4 2020 and held it in 12 quarters. The position peaked at $786K in Q1 2021. 625 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • Phoenix Wealth Advisors reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
  • Phoenix Wealth Advisors sold 5,620 Exact Sciences shares in Q1 2024, an estimated $415K.
  • Phoenix Wealth Advisors first reported a position in Exact Sciences in Q4 2020 and held it in 12 quarters.
  • Phoenix Wealth Advisors's Exact Sciences position peaked at $786K in Q1 2021.
  • 625 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Phoenix Wealth Advisors's 13F filing for Q1 2024, filed 26 Apr 2024.